Related Experiment Video
Updated: Jul 8, 2026

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility
Published on: April 13, 2017
Production and functions of IL-17 in microglia
Jun Kawanokuchi1, Kouki Shimizu, Atsumi Nitta
1Department of Neuroimmunology, Research Institute of Environmental Medicine, Nagoya University, Furo-cho, Chikusaku, Nagoya 464-8601, Japan.
Abstract:
Interleukin (IL)-17-producing helper T cells may play a pivotal role in the pathogenesis of multiple sclerosis. Here, we examined the effects of IL-17 on microglia, which are known to be critically involved in multiple sclerosis. Treatment with IL-17 upregulated the microglial production of IL-6, macrophage inflammatory protein-2, nitric oxide, adhesion molecules, and neurotrophic factors. We also found that IL-17 was produced by microglia in response to IL-23 or IL-1beta. Because microglia produce IL-1beta and IL-23, these cytokines may act in an autocrine manner to induce IL-17 expression in microglia, and thereby contribute to autoimmune diseases, such as MS, in the central nervous system.
Insights
Interleukin-17 (IL-17) influences microglia, key cells in multiple sclerosis (MS) pathogenesis. This study reveals IL-17 boosts microglial production of inflammatory and neurotrophic factors, potentially driving autoimmune responses in the central nervous system.
Area of Science:
- Neuroimmunology
- Cellular immunology
Background:
- Helper T cells producing Interleukin-17 (IL-17) are implicated in multiple sclerosis (MS) pathogenesis.
- Microglia are central to the inflammatory processes in MS.
Purpose of the Study:
- To investigate the effects of IL-17 on microglia.
- To explore the role of microglia-derived IL-17 in central nervous system autoimmunity.
Main Methods:
- Treatment of microglia with IL-17.
- Measurement of microglial cytokine and molecule production.
- Analysis of IL-17 production by microglia in response to other cytokines.
Main Results:
- IL-17 treatment upregulated microglial production of IL-6, macrophage inflammatory protein-2, nitric oxide, adhesion molecules, and neurotrophic factors.
- Microglia were found to produce IL-17 when stimulated with IL-23 or IL-1beta.
- Microglia's capacity to produce IL-1beta and IL-23 suggests autocrine signaling for IL-17 induction.
Conclusions:
- IL-17 modulates microglial function, promoting both inflammatory and potentially protective responses.
- Microglia-derived IL-17, induced by autocrine IL-1beta and IL-23, may contribute to autoimmune pathogenesis in the central nervous system, including MS.

